Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Cash Flows From Operating Activities | |
| Net Income | 29,034 |
| Depreciation Amortization | 5,348 |
| Income taxes - deferred | 335 |
| Other Working Capital | -50,313 |
| Other Operating Activity | 1,050 |
| Operating Cash Flow | $-14,546 |
| Cash Flows From Investing Activities | |
| PPE Investments | -228 |
| Other Investing Activity | -145,186 |
| Investing Cash Flow | $-145,414 |
| Cash Flows From Financing Activities | |
| Debt Issued | 103,242 |
| Common Stock Issued | 134,794 |
| Other Financing Activity | 976 |
| Financing Cash Flow | $239,012 |
| Beginning Cash Position | 4,722 |
| End Cash Position | 83,774 |
| Net Cash Flow | $79,052 |
| Free Cash Flow | |
| Operating Cash Flow | -14,546 |
| Capital Expenditure | -228 |
| Free Cash Flow | -14,774 |